Cumberland Pharmaceuticals, Inc. (CPIX)
7.39
-0.12
(-1.60%)
USD |
NASDAQ |
Oct 02, 16:00
7.39
0.00 (0.00%)
After-Hours: 20:00
Cumberland Pharmaceuticals Profit Margin (Quarterly) : -1.86K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.86K% |
| March 31, 2026 | -36.00% |
| December 31, 2025 | -10.44% |
| September 30, 2025 | -23.50% |
| June 30, 2025 | -787.3% |
| March 31, 2025 | 10.66% |
| December 31, 2024 | -18.22% |
| September 30, 2024 | -16.92% |
| June 30, 2024 | -11.20% |
| March 31, 2024 | -22.39% |
| December 31, 2023 | -67.38% |
| September 30, 2023 | -10.54% |
| June 30, 2023 | 7.92% |
| March 31, 2023 | 1.87% |
| December 31, 2022 | -26.96% |
| September 30, 2022 | -3.71% |
| June 30, 2022 | -13.25% |
| March 31, 2022 | -12.55% |
| December 31, 2021 | -52.74% |
| September 30, 2021 | -19.62% |
| June 30, 2021 | 8.00% |
| March 31, 2021 | -3.33% |
| December 31, 2020 | -17.42% |
| September 30, 2020 | -13.79% |
| June 30, 2020 | -17.49% |
| Date | Value |
|---|---|
| March 31, 2020 | -22.61% |
| December 31, 2019 | -36.21% |
| September 30, 2019 | -47.82% |
| June 30, 2019 | -14.21% |
| March 31, 2019 | -13.60% |
| December 31, 2018 | -16.57% |
| September 30, 2018 | -19.59% |
| June 30, 2018 | -7.33% |
| March 31, 2018 | -27.86% |
| December 31, 2017 | -7.05% |
| September 30, 2017 | -6.76% |
| June 30, 2017 | -59.73% |
| March 31, 2017 | -13.42% |
| December 31, 2016 | -8.48% |
| September 30, 2016 | 1.09% |
| June 30, 2016 | -0.82% |
| March 31, 2016 | -3.47% |
| December 31, 2015 | 1.60% |
| September 30, 2015 | 1.54% |
| June 30, 2015 | 4.43% |
| March 31, 2015 | 0.31% |
| December 31, 2014 | 6.95% |
| September 30, 2014 | 7.50% |
| June 30, 2014 | 7.28% |
| March 31, 2014 | 3.40% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.95% |
| Return on Assets | -14.18% |
| Return on Invested Capital | -30.16% |
| Operating Margin (Quarterly) | -1.76K% |
| Return on Net Operating Assets | -26.37% |